Literature DB >> 21675897

Bevacizumab for retinopathy of prematurity.

Laurence S Lim, Paul Mitchell, Tien Y Wong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21675897     DOI: 10.1056/NEJMc1103460

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?

Authors:  Andreas Stahl; Ann Hellstrom; Lois E H Smith
Journal:  Neonatology       Date:  2014-10-05       Impact factor: 4.035

2.  Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma?

Authors:  Rajvardhan Azad; Vivek Dave; Subhadra Jalali
Journal:  Indian J Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 1.848

3.  Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.

Authors:  Frank S Ong; Jane Z Kuo; Wei-Chi Wu; Ching-Yu Cheng; Wendell-Lamar B Blackwell; Brian L Taylor; Wayne W Grody; Jerome I Rotter; Chi-Chun Lai; Tien Y Wong
Journal:  J Pers Med       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.